Work

Treatment, thrombosis, and bleeding in patients with splenic infarcts

Year: 2025

Type: article

Abstract: • A new thrombotic risk found in 23% of patients, mainly AF and malignancy • Cryptogenic splenic infarction is rare • Most patients (58%) were discharged with any antithrombotic therapy. • Recurrent thrombosis at 1 year was high (19.6%), mainly arterial. • Major bleeding was also high (10%) and 1-year mortality was 50%

Source: Thrombosis Update

DOI: 10.1016/j.tru.2025.100230

Authors: Ela Giladi, Avi Leader, Lihi Pertman, Shlomit Tamir, Adi Rotkopf, Avishay Elis, Pia Raanani, Galia Spectre

Institutions: Tel Aviv University, Meir Medical Center, Memorial Sloan Kettering Cancer Center, Cornell University, Weill Cornell Medicine, Rabin Medical Center

Language: English

Topic: Abdominal vascular conditions and treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,090

Funders: Memorial Sloan-Kettering Cancer Center, National Institutes of Health, National Cancer Institute

Award: G3340923374

OpenAlex ID: W7110965499

FWCI:

Cites: 16

Cited by:

Related to: